posted on 2020-04-13, 17:10authored byKathrin Bach, Bert L. H. Beerkens, Patrick R. A. Zanon, Stephan M. Hacker
Covalent inhibitors
have recently seen a resurgence of interest
in drug development. Nevertheless, compounds, which do not rely on
an enzymatic activity, have almost exclusively been developed to target
cysteines. Expanding the scope to other amino acids would be largely
facilitated by the ability to globally monitor their engagement by
covalent inhibitors. Here, we present the use of light-activatable
2,5-disubstituted tetrazoles that allow quantifying 8971 aspartates
and glutamates in the bacterial proteome with excellent selectivity.
Using these probes, we competitively map the binding sites of two
isoxazolium salts and introduce hydrazonyl chlorides as a new class
of carboxylic-acid-directed covalent protein ligands. As the probes
are unreactive prior to activation, they allow global profiling even
in living Gram-positive and Gram-negative bacteria. Taken together,
this method to monitor aspartates and glutamates proteome-wide will
lay the foundation to efficiently develop covalent inhibitors targeting
these amino acids.